Agricultural Inputs Company Focused on Seed, Soil, & Plant Health
Agricultural Inputs Manufacturer in the Southeastern USA
On NextCompany since September 30, 2026 (15 days)
Location undisclosed
Business overview
This Southeastern USA manufacturer develops agricultural inputs for seed, soil, and plant health. Its 50-year history includes proprietary biostimulant, nutrient, and micronutrient formulations. The company serves U.S. and Canadian row crop growers, plus specialty crop, turf, greenhouse, and nursery markets. It handles formulation, manufacturing, packaging, and distribution.
Gross revenue totals $8,770,118, with EBITDA of $2,213,096. Repeat customers, long-tenured sales consultants, and an early-order program support sales. The company owns an approximately 40,000 sq. ft. headquarters, which the owners expect to include in the sale. Growth avenues include geographic expansion, new formulations, and distributors; the owners remain open to negotiable transition periods.
Who is a good fit for this business
- Agricultural input manufacturers seeking integrated formulation, manufacturing, packaging, and distribution capabilities.
- Distributors serving row crop growers in the U.S. and Canada who seek proprietary biostimulant and micronutrient formulations.
Details
- Real estate
- Owned, included in sale
Frequently Asked Questions
The company develops proprietary biostimulant, nutrient, and micronutrient formulations for seed, soil, and plant health. It serves U.S. and Canadian row crop growers, plus specialty crop, turf, greenhouse, and nursery markets.
The company combines formulation, manufacturing, packaging, and distribution in its operation. Long-tenured sales consultants serve repeat customers, and an established early-order program supports sales.
The listing reports gross revenue of $8,770,118 and EBITDA of $2,213,096. Those figures describe different measures of the company's financial performance.
The company owns an approximately 40,000 sq. ft. headquarters. The owners expect to include the property in the sale.
The company identifies geographic expansion, new formulations, and distributors as growth avenues. The owners remain open to negotiable transition periods.